Our regulatory-grade Data as a Service platform accelerates personalized medicine by expediting evidence generation and regulatory reviews of new treatments. The platform is the sole bioinformatics platform used by the FDA for its regulatory evaluation of bioinformatics pipelines as part of new personalized medicine products. It also powers the FDA's ARGOS reference genomic database for pathogens such as SARS-CoV-2 & influenza. Embleema collects, curates and generates regulatory-grade data and powers Real-World Data (RWD) platforms for the Epilepsy Foundation, Multiple Sclerosis Association of America, life sciences companies such as Galderma, and care and research centers such as NYU Langone, George Washington University, UCSF, Yale and Mayo Clinic.

Our working group develops the framework for evaluating mobile health applications and devices, including guidelines and/or standards for data privacy, security, accuracy, and interoperability.

Leading product development, marketing and strategy for healthcare, including the creation of the Nokia Patient Care platform and digital chronic disease management solutions.

In charge of creating solutions and partnerships to boost the use of Patient-Generated Health Data by providers, medical researchers and employers.Withings was acquired by Nokia in May 2016 for €170M.

SmartConsult is a connected health solution to help neurologists diagnose postural deficits in order to improve patient follow-up and prediction of falls.

Structuring and ABS Valuation Team, Securitization - Fixed Income Department